Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Reuters NewMedia - November 28, 2008
Stephanie Nebehay
Paul De Lay, a director in the U.N. anti-AIDS agency, said the crisis was of great concern for development programmes as governments examined their budgets.
The world must maintain current assistance levels, he told a briefing before World Aids Day on Monday.
"(Or) what we'll find in the next four or five years is a resurgence in new incident infections and we won't be able to scale up the treatment that is clearly going to be needed as more and more people become symptomatic and need access to drugs," he said.
An estimated 33 million people worldwide were living with the HIV virus, mostly in sub-Saharan Africa, at the end of 2007. AIDS has killed 25 million since being identified in 1981.
An estimated 2.7 million people become infected each year.
Treatment programmes which provide life-extending drugs have expanded and now reach nearly 4 million people, De Lay said. That fell short of the estimated 9.7 million in need of antiretrovirals.
Five new people are infected each year for every two put on treatment, De Lay said.
The Geneva-based agency said in its AIDS Outlook 2009 report that even though political commitment for AIDS was at an all-time high "recent developments in the financial world will test the resilience of many".
It identified three trends.
In Thailand, new infections arising in men who have sex with men, is at alarming levels, it said.
In Uganda, most new infections occur as a result of people having multiple sex partners.
A third trend was identified in Kenya, where many new infections occur in sex workers, injecting drug users and men having sex with men.
(Editing by Angus MacSwan)
081128
RE081129
Copyright © 2008 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .